The report on the global peptide therapeutics market provides qualitative and quantitative analysis for the period from 2021-2030. The report predicts the global peptide therapeutics market to grow with a CAGR of Around 10% over the forecast period from 2023-2030. The study on peptide therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.
The report on peptide therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global peptide therapeutics market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global peptide therapeutics market over the period of 2021-2030. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
2. Complete coverage of all the segments in the peptide therapeutics market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global peptide therapeutics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
The report on peptide therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global peptide therapeutics market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global peptide therapeutics market over the period of 2021-2030. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Report Findings
1) Drivers
- The rising prevalence of metabolic disorders coupled with an increasing pool of cancer patients.
- Rising research activities and the development pipeline of peptide drugs are anticipated to drive the growth of the market.
2) Restraints
- Strict regulatory prerequisites for drug approval are expected to limit market growth.
3) Opportunities
- The increasing incidence of metabolic disorders across the globe will also be expected to create numerous growth opportunities in the forthcoming years.
Research Methodology
A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry
The primary research respondents typically include
1. Executives working with leading companies in the market under review2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.The secondary sources of the data typically include
1. Company reports and publications2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
Segment Covered
The global peptide therapeutics market is segmented on the basis of product type, application, and route of administration.The Global Peptide Therapeutics Market by Product Type
- Generic
- Branded
The Global Peptide Therapeutics Market by Application
- Gastrointestinal Disorders
- Neurological Disorders
- Metabolic Disorders
- Cancer
- Other Application
The Global Peptide Therapeutics Market by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
Company Profiles
The companies covered in the report include- Teva Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
- Sanofi
- Pfizer Inc.
- Novartis AG
- GSK plc
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Company
- Bachem
- Amgen Inc.
What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the peptide therapeutics market.2. Complete coverage of all the segments in the peptide therapeutics market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global peptide therapeutics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Table of Contents
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Global Peptide Therapeutics Market Overview
Chapter 5. Global Peptide Therapeutics Market by Product Type
Chapter 6. Global Peptide Therapeutics Market by Application
Chapter 7. Global Peptide Therapeutics Market by Route Of Administration
Chapter 8. Global Peptide Therapeutics Market by Region 2023-2030
Chapter 9. Company Profiles and Competitive Landscape
Companies Mentioned
- Teva Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
- Sanofi
- Pfizer Inc.
- Novartis AG
- GSK plc
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Company
- Bachem
- Amgen Inc.
